Novo Nordisk Wins FDA Approval for Weight-Loss Pill, Alphabet Buys Clean Energy Provider
The Rundown
00:00
Novo Nordisk's GLP-1 Pill Approval
Zaid details FDA approval for WeGovie pill, pricing, market impact, and competitive pressure from Eli Lilly.
Play episode from 02:24
Transcript
